The members of the International Working Party

References

Table A

Table B



The members of the International Working Party to Promote and Revitalise Academic Medicine are Tahmeed Ahmed (Scientist, Clinical Sciences Division, ICDDRB, Dhaka, Bangladesh), Shally Awasthi (Professor, Department of Paediatrics, King George’s Medical University, Lucknow, India), A Mark Clarfield (Professor, Department of Geriatrics, Soroka Hospital, Ben-Gurion University of the Negev, Beersheva, Israel), Lalit Dandona (Director, Centre for Public Health Research, Administrative Staff College of India, Hyderabad, India), Amanda Howe (Professor of Primary Care, School of Medicine, University of East Anglia, Norfolk, UK), John P A Ioannidis (Chairman, Department of Hygiene & Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece), Edwin C Jesudason (Academy of Medical Sciences National Clinician Scientist, Health Foundation Leadership Fellow and Lecturer in Paediatric Surgery, School of Reproductive and Developmental Health, University of Liverpool, Liverpool, UK), Youping Li (Director, Chinese Cochrane Centre, West China Hospital, Sichuan University, Chengdu, China), Juan Manuel Lozano (Professor, Department of Pediatrics and Clinical Epidemiology, Javeriana University School of Medicine, Bogota, Colombia), Ana Marusic (Professor, Department of Anatomyal, Zagreb University School of Medicine, and Editor, Croatian Medical Journal, Zagreb, Croatia), Idris Mohammed (Outgoing Provost, College of Medical Sciences, Department of Medicine and Clinical Immunology, University of Maiduguri, Maiduguri, Nigeria), Gretchen P Purcell (Paediatric Surgery Fellow, Pittsburgh Children’s Hospital, Pittsburgh, USA), Karen Sliwa-Hähnle (Professor, Department of Cardiology, CH Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South Africa), Sharon E Straus (Associate Professor, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Canada), Tessa Tan-Torres Edejer (Scientist, Department of Health Systems Financing, Expenditure and Resource Allocation, WHO, Geneva, Switzerland), Timothy J Underwood (Medical Research Council / Royal College of Surgeons Clinical Research Training Fellow, University of Southampton, Southampton, UK), Robyn Ward (Associate Professor, Department of Medical Oncology, St Vincent’s Hospital, Darlinghurst, and School of Medicine, University of New South Wales, Australia), Michael S Wilkes (Vice Dean and Professor of Medicine, School of Medicine, University of California Davis, Davis, USA), David Wilkinson (Deputy Head and Professor of Primary Care, School of Medicine, University of Queensland, Brisbane, Australia), and Sachi Sivananthan (Medical Student, Guy’s, King’s & St Thomas’ Medical School, King’s College London, UK).

 

References

w1 Society for Academic Emergency Medicine. Faculty development.www.saem.org/facdev/index.htm (accessed 14 Sep 2004)

w2 Boyer EL. Scholarship reconsidered: priorities of the professoriate. Princeton, NJ: Carnegie Foundation for the Advancement of Teaching, 1990.

w3 Canadian Institute for Health Information. Canada’s health care providers. Planning for the future: the supply of health care providers. http://secure.cihi.ca/cihiweb/home-e.html (accessed 14 Sep 2004).

w4 Anonymous. Physician workforce in Canada. http://.physicianhr.ca/home-e.php (accessed 14 Sep 2004).

w5 Bickel J, Wara D, Atkinson BF, Cohen LS, Dunn M, Hostler S, et al. Increasing women’s leadership in academic medicine: report of the AAMC project implementation committee. Acad Med 2002;77:1043-61.

w6 Thomas PA, Diener-West M, Canto MI, Martin DR, Post WS,Streiff MB. Results of an academic promotion and career path survey of faculty at the Johns Hopkins University School of Medicine. Acad Med 2004;79:258-64.

w7 Kelley WN, Stross JK. Faculty tracks and academic success. Ann Intern Med 1992;116:654-9.

w8 Oinonen MJ, Crowley WF, Moskowitz J, Vlasses PH. How do academic health centers value and encourage clinical research. Acad Med 2001;76:700-6.

w9 Jackson VA, Palepu A, Szalacha L, Caswell C, Carr PL, Inui T. "Having the right chemistry": a qualitative study of mentoring in academic medicine. Acad Med 2003;78:328-34.

w10. McGuire LK, Bergen MR, Polan M. Career advancement for women faculty in a US school of medicine. Acad Med 2004;79:319-25.

w11 United Nations Development Programme (UNDP). Economic performance. In: UNDP. Human development report 2003. New York: UNDP, 2003:237-40.

w12 Isaakidis P, Swingler GH, Pienaar E, Volmink J, Ioannidis JP. Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research. BMJ 2002;324:702-5.

w13 Ioannidis JP. Global estimates of high-level brain drain and deficit. FASEB J 2004;18:936-9.

w14 Gibbs WW. Lost science in the third world. Sci Am 1995;273 :92-99

w15 Institute for Scientific Information. Highly cited scientists. www.isihighlycited.com (accessed 6 Jul 2004).

w16 Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003;289:454-65.

w16 Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-70.


 

Table A Authors of the 100 most cited papers in life sciences who have industry affiliations

Domain

Lead author*

Any author

     

Clinical medicine

8

26

Social sciences, general

0

0

Immunology

13

29

Molecular biology and genetics

8

17

Pharmacology

20

31

Biology and biochemistry

14

17

Microbiology

5

20

Neurosciences and behavior

11

22

Psychology or psychiatry

2

5

*First affiliation listed in the ISI record. Data from ISI Essential Science Indicators up to 30 April 2004.


 

Table B The eight most cited randomised controlled trials in clinical medicine, 1994-2004

Trial

Intervention

Funding*

No of citations

NEJM 1995;333:1301

Pravastatin

Bristol-Myers-Squibb

2993

NEJM 1996;335:1001

Pravastatin

Bristol-Myers-Squibb

2610

NEJM 1994;331:489

Coronary stents

Johnson and Johnson and other industry

2208

NEJM 1994;331:496

Coronary stents

Johnson and Johnson

1971

JAMA 1998;280:605

Oestrogen+progestin

Wyeth-Ayerst

1914

NEJM 1996;334:1349

Carvedilol

SmithKlineBeecham and Boehringer Mannheim

1464

Lancet 1998;351:1755

Anti-hypertensives

Astra Zeneca and other industry

1455

JAMA 1998;279:1615

Lovastatin

Merck

1452

Citations from ISI Essential Science Indicators up to 30 April 2004; funding from trial reports.

*None of these trials was funded by any organization other than industry.